APO Research
Talk to an analyst

APO RESEARCH · REPORT

Genome Sequencing Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Genome Sequencing Service Market Outlook and Growth Opportunities 2026

4 January 2026201 pages

Choose your research edition.

Industry ResearchGenome Sequencing Service Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal Genome Sequencing Service Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Genome Sequencing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Genome Sequencing Service Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Genome Sequencing Service Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Genome Sequencing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Genome Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Genome Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Genome Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Genome Sequencing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Genome Sequencing Service market include Illumina, Thermo Fisher Scientific, BGI Genomics, Agilent Technologies, CD Genomics, Azenta Life Sciences, Broad Clinical Labs, Macrogen and GE Healthcare Life Sciences, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Genome Sequencing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Genome Sequencing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Genome Sequencing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Genome Sequencing Service market.

Genome Sequencing Service Segment by Company

Illumina

Thermo Fisher Scientific

BGI Genomics

Agilent Technologies

CD Genomics

Azenta Life Sciences

Broad Clinical Labs

Macrogen

GE Healthcare Life Sciences

Johnson & Johnson

Abbott Laboratories

Bayer

Microchip Biotechnologies

GeneDx

Commonwealth Biotechnologies

ZS Genetics

Pacific Biosciences

Novogene

Eurofins Genomics

Psomagen

Genome Sequencing Service Segment by Type

Whole-Genome Sequencing

Whole exome Sequencing

Others

Genome Sequencing Service Segment by Application

Humanity

Plant

Animal

Microorganism

Virus

Genome Sequencing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Genome Sequencing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Genome Sequencing Service key companies, revenue, market share, and recent developments.

3. To split the Genome Sequencing Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Genome Sequencing Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Genome Sequencing Service significant trends, drivers, influence factors in global and regions.

6. To analyze Genome Sequencing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genome Sequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genome Sequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genome Sequencing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Genome Sequencing Service industry.

Chapter 3: Detailed analysis of Genome Sequencing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Genome Sequencing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Genome Sequencing Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Genome Sequencing Service Industry Trends Table 2. Genome Sequencing Service Industry Drivers Table 3. Genome Sequencing Service Industry Opportunities and Challenges Table 4. Genome Sequencing Service Industry Restraints Table 5. Global Genome Sequencing Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Genome Sequencing Service Revenue Share by Company (2021-2026) Table 7. Global Genome Sequencing Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Genome Sequencing Service Key Company Manufacturing Base & Headquarters Table 9. Global Genome Sequencing Service Company, Product Type & Application Table 10. Global Genome Sequencing Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Genome Sequencing Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Whole-Genome Sequencing Table 15. Significant Companies of Whole exome Sequencing Table 16. Significant Companies of Others Table 17. Global Genome Sequencing Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Genome Sequencing Service Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Genome Sequencing Service Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Genome Sequencing Service Sales Value Share by Type (2021-2026) Table 21. Global Genome Sequencing Service Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Humanity Table 23. Significant Companies of Plant Table 24. Significant Companies of Animal Table 25. Significant Companies of Microorganism Table 26. Significant Companies of Virus Table 27. Global Genome Sequencing Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Genome Sequencing Service Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Genome Sequencing Service Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Genome Sequencing Service Sales Value Share by Application (2021-2026) Table 31. Global Genome Sequencing Service Sales Value Share by Application (2027-2032) Table 32. Global Genome Sequencing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Genome Sequencing Service Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Genome Sequencing Service Sales Value Share by Region (2021-2026) Table 35. Global Genome Sequencing Service Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Genome Sequencing Service Sales Value Share by Region (2027-2032) Table 37. Global Genome Sequencing Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Genome Sequencing Service Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Genome Sequencing Service Sales Value Market Share by Country (2021-2026) Table 40. Global Genome Sequencing Service Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Genome Sequencing Service Sales Value Market Share by Country (2027-2032) Table 42. Illumina Company Information Table 43. Illumina Business Overview Table 44. Illumina Genome Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Illumina Genome Sequencing Service Product Portfolio Table 46. Illumina Recent Development Table 47. Thermo Fisher Scientific Company Information Table 48. Thermo Fisher Scientific Business Overview Table 49. Thermo Fisher Scientific Genome Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Thermo Fisher Scientific Genome Sequencing Service Product Portfolio Table 51. Thermo Fisher Scientific Recent Development Table 52. BGI Genomics Company Information Table 53. BGI Genomics Business Overview Table 54. BGI Genomics Genome Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. BGI Genomics Genome Sequencing Service Product Portfolio Table 56. BGI Genomics Recent Development Table 57. Agilent Technologies Company Information Table 58. Agilent Technologies Business Overview Table 59. Agilent Technologies Genome Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Agilent Technologies Genome Sequencing Service Product Portfolio Table 61. Agilent Technologies Recent Development Table 62. CD Genomics Company Information Table 63. CD Genomics Business Overview Table 64. CD Genomics Genome Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. CD Genomics Genome Sequencing Service Product Portfolio Table 66. CD Genomics Recent Development Table 67. Azenta Life Sciences Company Information Table 68. Azenta Life Sciences Business Overview Table 69. Azenta Life Sciences Genome Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Azenta Life Sciences Genome Sequencing Service Product Portfolio Table 71. Azenta Life Sciences Recent Development Table 72. Broad Clinical Labs Company Information Table 73. Broad Clinical Labs Business Overview Table 74. Broad Clinical Labs Genome Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Broad Clinical Labs Genome Sequencing Service Product Portfolio Table 76. Broad Clinical Labs Recent Development Table 77. Macrogen Company Information Table 78. Macrogen Business Overview Table 79. Macrogen Genome Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Macrogen Genome Sequencing Service Product Portfolio Table 81. Macrogen Recent Development Table 82. GE Healthcare Life Sciences Company Information Table 83. GE Healthcare Life Sciences Business Overview Table 84. GE Healthcare Life Sciences Genome Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. GE Healthcare Life Sciences Genome Sequencing Service Product Portfolio Table 86. GE Healthcare Life Sciences Recent Development Table 87. Johnson & Johnson Company Information Table 88. Johnson & Johnson Business Overview Table 89. Johnson & Johnson Genome Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Johnson & Johnson Genome Sequencing Service Product Portfolio Table 91. Johnson & Johnson Recent Development Table 92. Abbott Laboratories Company Information Table 93. Abbott Laboratories Business Overview Table 94. Abbott Laboratories Genome Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Abbott Laboratories Genome Sequencing Service Product Portfolio Table 96. Abbott Laboratories Recent Development Table 97. Bayer Company Information Table 98. Bayer Business Overview Table 99. Bayer Genome Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Bayer Genome Sequencing Service Product Portfolio Table 101. Bayer Recent Development Table 102. Microchip Biotechnologies Company Information Table 103. Microchip Biotechnologies Business Overview Table 104. Microchip Biotechnologies Genome Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Microchip Biotechnologies Genome Sequencing Service Product Portfolio Table 106. Microchip Biotechnologies Recent Development Table 107. GeneDx Company Information Table 108. GeneDx Business Overview Table 109. GeneDx Genome Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. GeneDx Genome Sequencing Service Product Portfolio Table 111. GeneDx Recent Development Table 112. Commonwealth Biotechnologies Company Information Table 113. Commonwealth Biotechnologies Business Overview Table 114. Commonwealth Biotechnologies Genome Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Commonwealth Biotechnologies Genome Sequencing Service Product Portfolio Table 116. Commonwealth Biotechnologies Recent Development Table 117. ZS Genetics Company Information Table 118. ZS Genetics Business Overview Table 119. ZS Genetics Genome Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. ZS Genetics Genome Sequencing Service Product Portfolio Table 121. ZS Genetics Recent Development Table 122. Pacific Biosciences Company Information Table 123. Pacific Biosciences Business Overview Table 124. Pacific Biosciences Genome Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Pacific Biosciences Genome Sequencing Service Product Portfolio Table 126. Pacific Biosciences Recent Development Table 127. Novogene Company Information Table 128. Novogene Business Overview Table 129. Novogene Genome Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Novogene Genome Sequencing Service Product Portfolio Table 131. Novogene Recent Development Table 132. Eurofins Genomics Company Information Table 133. Eurofins Genomics Business Overview Table 134. Eurofins Genomics Genome Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Eurofins Genomics Genome Sequencing Service Product Portfolio Table 136. Eurofins Genomics Recent Development Table 137. Psomagen Company Information Table 138. Psomagen Business Overview Table 139. Psomagen Genome Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Psomagen Genome Sequencing Service Product Portfolio Table 141. Psomagen Recent Development Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Genome Sequencing Service Product Image Figure 2. Global Genome Sequencing Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Genome Sequencing Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Genome Sequencing Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Whole-Genome Sequencing Image Figure 8. Whole exome Sequencing Image Figure 9. Others Image Figure 10. Global Genome Sequencing Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Genome Sequencing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Genome Sequencing Service Sales Value Share by Type (2021-2032) Figure 13. Humanity Image Figure 14. Plant Image Figure 15. Animal Image Figure 16. Microorganism Image Figure 17. Virus Image Figure 18. Global Genome Sequencing Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Genome Sequencing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Genome Sequencing Service Sales Value Share by Application (2021-2032) Figure 21. Global Genome Sequencing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Genome Sequencing Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Genome Sequencing Service Sales Value (2021-2032) & (US$ Million) Figure 24. North America Genome Sequencing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Genome Sequencing Service Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Genome Sequencing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Genome Sequencing Service Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Genome Sequencing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Genome Sequencing Service Sales Value (2021-2032) & (US$ Million) Figure 30. South America Genome Sequencing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Genome Sequencing Service Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Genome Sequencing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Genome Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Whole-Genome Sequencing
  • Whole exome Sequencing
  • Others
Applications
  • Humanity
  • Plant
  • Animal
  • Microorganism
  • Virus
Companies covered
  • Illumina
  • Thermo Fisher Scientific
  • BGI Genomics
  • Agilent Technologies
  • CD Genomics
  • Azenta Life Sciences
  • Broad Clinical Labs
  • Macrogen
  • GE Healthcare Life Sciences
  • Johnson & Johnson
  • Abbott Laboratories
  • Bayer
  • Microchip Biotechnologies
  • GeneDx
  • Commonwealth Biotechnologies
  • ZS Genetics
  • Pacific Biosciences
  • Novogene
  • Eurofins Genomics
  • Psomagen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Genome Sequencing Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Genome Sequencing Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Genome Sequencing Service Market Dynamics
  1. 2.1 Genome Sequencing Service Industry Trends
  2. 2.2 Genome Sequencing Service Industry Drivers
  3. 2.3 Genome Sequencing Service Industry Opportunities and Challenges
  4. 2.4 Genome Sequencing Service Industry Restraints
3 Genome Sequencing Service Market by Company
  1. 3.1 Global Genome Sequencing Service Company Revenue Ranking in 2025
  2. 3.2 Global Genome Sequencing Service Revenue by Company (2021-2026)
  3. 3.3 Global Genome Sequencing Service Company Ranking (2024-2026)
  4. 3.4 Global Genome Sequencing Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Genome Sequencing Service Company Product Type and Application
  6. 3.6 Global Genome Sequencing Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Genome Sequencing Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Genome Sequencing Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Genome Sequencing Service Market by Type
  1. 4.1 Genome Sequencing Service Type Introduction
  2. 4.1.1 Whole-Genome Sequencing
  3. 4.1.2 Whole exome Sequencing
  4. 4.1.3 Others
  5. 4.2 Global Genome Sequencing Service Sales Value by Type
  6. 4.2.1 Global Genome Sequencing Service Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Genome Sequencing Service Sales Value by Type (2021-2032)
  8. 4.2.3 Global Genome Sequencing Service Sales Value Share by Type (2021-2032)
5 Genome Sequencing Service Market by Application
  1. 5.1 Genome Sequencing Service Application Introduction
  2. 5.1.1 Humanity
  3. 5.1.2 Plant
  4. 5.1.3 Animal
  5. 5.1.4 Microorganism
  6. 5.1.5 Virus
  7. 5.2 Global Genome Sequencing Service Sales Value by Application
  8. 5.2.1 Global Genome Sequencing Service Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Genome Sequencing Service Sales Value by Application (2021-2032)
  10. 5.2.3 Global Genome Sequencing Service Sales Value Share by Application (2021-2032)
6 Genome Sequencing Service Regional Value Analysis
  1. 6.1 Global Genome Sequencing Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Genome Sequencing Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Genome Sequencing Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Genome Sequencing Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Genome Sequencing Service Sales Value (2021-2032)
  7. 6.3.2 North America Genome Sequencing Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Genome Sequencing Service Sales Value (2021-2032)
  10. 6.4.2 Europe Genome Sequencing Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Genome Sequencing Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Genome Sequencing Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Genome Sequencing Service Sales Value (2021-2032)
  16. 6.6.2 South America Genome Sequencing Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Genome Sequencing Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Genome Sequencing Service Sales Value Share by Country, 2025 VS 2032
7 Genome Sequencing Service Country-level Value Analysis
  1. 7.1 Global Genome Sequencing Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Genome Sequencing Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Genome Sequencing Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Genome Sequencing Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Genome Sequencing Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Illumina
  2. 8.1.1 Illumina Company Information
  3. 8.1.2 Illumina Business Overview
  4. 8.1.3 Illumina Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Illumina Genome Sequencing Service Product Portfolio
  6. 8.1.5 Illumina Recent Developments
  7. 8.2 Thermo Fisher Scientific
  8. 8.2.1 Thermo Fisher Scientific Company Information
  9. 8.2.2 Thermo Fisher Scientific Business Overview
  10. 8.2.3 Thermo Fisher Scientific Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific Genome Sequencing Service Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Recent Developments
  13. 8.3 BGI Genomics
  14. 8.3.1 BGI Genomics Company Information
  15. 8.3.2 BGI Genomics Business Overview
  16. 8.3.3 BGI Genomics Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BGI Genomics Genome Sequencing Service Product Portfolio
  18. 8.3.5 BGI Genomics Recent Developments
  19. 8.4 Agilent Technologies
  20. 8.4.1 Agilent Technologies Company Information
  21. 8.4.2 Agilent Technologies Business Overview
  22. 8.4.3 Agilent Technologies Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Agilent Technologies Genome Sequencing Service Product Portfolio
  24. 8.4.5 Agilent Technologies Recent Developments
  25. 8.5 CD Genomics
  26. 8.5.1 CD Genomics Company Information
  27. 8.5.2 CD Genomics Business Overview
  28. 8.5.3 CD Genomics Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CD Genomics Genome Sequencing Service Product Portfolio
  30. 8.5.5 CD Genomics Recent Developments
  31. 8.6 Azenta Life Sciences
  32. 8.6.1 Azenta Life Sciences Company Information
  33. 8.6.2 Azenta Life Sciences Business Overview
  34. 8.6.3 Azenta Life Sciences Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Azenta Life Sciences Genome Sequencing Service Product Portfolio
  36. 8.6.5 Azenta Life Sciences Recent Developments
  37. 8.7 Broad Clinical Labs
  38. 8.7.1 Broad Clinical Labs Company Information
  39. 8.7.2 Broad Clinical Labs Business Overview
  40. 8.7.3 Broad Clinical Labs Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Broad Clinical Labs Genome Sequencing Service Product Portfolio
  42. 8.7.5 Broad Clinical Labs Recent Developments
  43. 8.8 Macrogen
  44. 8.8.1 Macrogen Company Information
  45. 8.8.2 Macrogen Business Overview
  46. 8.8.3 Macrogen Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Macrogen Genome Sequencing Service Product Portfolio
  48. 8.8.5 Macrogen Recent Developments
  49. 8.9 GE Healthcare Life Sciences
  50. 8.9.1 GE Healthcare Life Sciences Company Information
  51. 8.9.2 GE Healthcare Life Sciences Business Overview
  52. 8.9.3 GE Healthcare Life Sciences Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 GE Healthcare Life Sciences Genome Sequencing Service Product Portfolio
  54. 8.9.5 GE Healthcare Life Sciences Recent Developments
  55. 8.10 Johnson & Johnson
  56. 8.10.1 Johnson & Johnson Company Information
  57. 8.10.2 Johnson & Johnson Business Overview
  58. 8.10.3 Johnson & Johnson Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Johnson & Johnson Genome Sequencing Service Product Portfolio
  60. 8.10.5 Johnson & Johnson Recent Developments
  61. 8.11 Abbott Laboratories
  62. 8.11.1 Abbott Laboratories Company Information
  63. 8.11.2 Abbott Laboratories Business Overview
  64. 8.11.3 Abbott Laboratories Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Abbott Laboratories Genome Sequencing Service Product Portfolio
  66. 8.11.5 Abbott Laboratories Recent Developments
  67. 8.12 Bayer
  68. 8.12.1 Bayer Company Information
  69. 8.12.2 Bayer Business Overview
  70. 8.12.3 Bayer Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Bayer Genome Sequencing Service Product Portfolio
  72. 8.12.5 Bayer Recent Developments
  73. 8.13 Microchip Biotechnologies
  74. 8.13.1 Microchip Biotechnologies Company Information
  75. 8.13.2 Microchip Biotechnologies Business Overview
  76. 8.13.3 Microchip Biotechnologies Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Microchip Biotechnologies Genome Sequencing Service Product Portfolio
  78. 8.13.5 Microchip Biotechnologies Recent Developments
  79. 8.14 GeneDx
  80. 8.14.1 GeneDx Company Information
  81. 8.14.2 GeneDx Business Overview
  82. 8.14.3 GeneDx Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 GeneDx Genome Sequencing Service Product Portfolio
  84. 8.14.5 GeneDx Recent Developments
  85. 8.15 Commonwealth Biotechnologies
  86. 8.15.1 Commonwealth Biotechnologies Company Information
  87. 8.15.2 Commonwealth Biotechnologies Business Overview
  88. 8.15.3 Commonwealth Biotechnologies Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Commonwealth Biotechnologies Genome Sequencing Service Product Portfolio
  90. 8.15.5 Commonwealth Biotechnologies Recent Developments
  91. 8.16 ZS Genetics
  92. 8.16.1 ZS Genetics Company Information
  93. 8.16.2 ZS Genetics Business Overview
  94. 8.16.3 ZS Genetics Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 ZS Genetics Genome Sequencing Service Product Portfolio
  96. 8.16.5 ZS Genetics Recent Developments
  97. 8.17 Pacific Biosciences
  98. 8.17.1 Pacific Biosciences Company Information
  99. 8.17.2 Pacific Biosciences Business Overview
  100. 8.17.3 Pacific Biosciences Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Pacific Biosciences Genome Sequencing Service Product Portfolio
  102. 8.17.5 Pacific Biosciences Recent Developments
  103. 8.18 Novogene
  104. 8.18.1 Novogene Company Information
  105. 8.18.2 Novogene Business Overview
  106. 8.18.3 Novogene Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Novogene Genome Sequencing Service Product Portfolio
  108. 8.18.5 Novogene Recent Developments
  109. 8.19 Eurofins Genomics
  110. 8.19.1 Eurofins Genomics Company Information
  111. 8.19.2 Eurofins Genomics Business Overview
  112. 8.19.3 Eurofins Genomics Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Eurofins Genomics Genome Sequencing Service Product Portfolio
  114. 8.19.5 Eurofins Genomics Recent Developments
  115. 8.20 Psomagen
  116. 8.20.1 Psomagen Company Information
  117. 8.20.2 Psomagen Business Overview
  118. 8.20.3 Psomagen Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Psomagen Genome Sequencing Service Product Portfolio
  120. 8.20.5 Psomagen Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst